𝔖 Bobbio Scriptorium
✦   LIBER   ✦

G-CSF and IL-6 serum-levels in patients with myelodysplastic syndromes and aplastic anemia

✍ Scribed by C. Nerl; T. Kamp; G. Reisbach; C. Zink; F. Abedinpour; W. Kaboth; P. Dormer

Book ID
116167812
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
132 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of androgen therapy and anemia on
Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes
✍ Piedras, Josefa; HernΓ‘ndez, Guadalupe; LΓ³pez-Karpovitch, Xavier πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 53 KB πŸ‘ 2 views

Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.